Status:

UNKNOWN

Analgesic Effect of Anahil and Ibuprofen on Pain After Root Canal Therapy in Patients With Pulpitis of the Molars in Qazvin(a City in Iran)

Lead Sponsor:

Qazvin University Of Medical Sciences

Conditions:

Irreversible Pulpitis

Eligibility:

All Genders

20-40 years

Phase:

PHASE2

Brief Summary

Hypothesis: 0: The analgesic effect of Ibuprofen and Anahil would be the same in reducing the pain after root canal therapy. 1: Ibuprofen shows higher potency to reduce the pain after root canal the...

Detailed Description

Patients will be selected from those who are referred to receive root canal therapy for the mandibular first molars with irreversible pulpitis. The current research and all the procedures will be don...

Eligibility Criteria

Inclusion

  • Patients report spontaneous pain of the first molar of mandible ranging from 50 to 100 mm on a VAS (0-100 mm)
  • The dental pulp's condition is irreversible pulpitis and the tooth is reparable and need the root canal therapy
  • No evidences of any lesions and lucency, PDL widening, loss of lamina dura in radiographic examination
  • Patients aged 20 to 50 years from both genders
  • Patients are not pregnant or breast-feeding
  • Healthy periodontal status (no evidences of aggressive/chronic periodontal diseases)
  • No history of any systemic diseases (specially gastrointestinal and coagulation disorders)
  • No history of allergic reaction to food nutrients (specially pineapple, celery, carrot, and fennel), NSAIDs and lidocaine
  • No history of consuming the drugs interfere with NSAIDs, lidocaine and anticoagulants
  • No use of other analgesic drugs within the last 6 hours
  • Existence of no large restorations or crowns in treated tooth
  • patients have no extreme fear of dental procedure
  • Teeth with no evidence of infection or sinus tract
  • Patients did not a previous RCT

Exclusion

  • Patients who leave the study because of any reasons
  • Special anatomy of teeth (extra canals, severe root curvature, calcifications, open apex, C shape, fractures,..)
  • Patients who are not able to tolerate the single-session treatment (time, tooth's situation,..)
  • If the aspiration through IAN block injection is positive
  • If the diagnosis of pulp status has changed to partial necrosis during access cavity preparation

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

72 Patients enrolled

Trial Details

Trial ID

NCT05349929

Start Date

May 1 2022

End Date

December 1 2022

Last Update

April 27 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.